The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

World Health Organization Recommends Global Use of Newest Hepatitis C Drugs, Urges Price Reductions

April 10, 2014

This article was reported by NAM aidsmap.

NAM aidsmap reported that the World Health Organization (WHO) recently released new hepatitis C treatment guidelines. The guidelines call for global usage of Gilead's new drug, Sovaldi, while encouraging a price reduction of the $84,000-per-treatment medication. The drug must be used in combination with other medication, depending on genotype.

Gilead recently negotiated a price reduction of Sovaldi with Egypt to provide the drug at a price of $1,200 per 12-week course. It currently is seeking voluntary licenses to allow pharmaceutical companies in India to produce and distribute Sovaldi to 60 counties in Africa and Asia for $2,000-per-treatment-course. "I hope these guidelines will help to promote a reduction in price and thereby an increase in access," said Stefan Wiktor, head of the WHO hepatitis program. WHO completed its guidelines before Gilead negotiated pricing in countries outside the United States.

View Full Article

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

See Also
Talk to a Physician About HIV/Hepatitis Coinfection in Our "Ask the Experts" Forums
More News on Hepatitis C Treatment

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: